About Careers Internship MedBlog Contact us

Therapeutic HIV Vaccine is Not Effective: Clinical Trial

by Hannah Joy on December 11, 2017 at 3:09 PM
Therapeutic HIV Vaccine is Not Effective: Clinical Trial

A therapeutic HIV vaccine was found to have no effect on suppressing HIV in the absence of antiretroviral therapy (ART), reveals a new study.

A randomized, double-blind, placebo-controlled clinical trial found no benefit, but could offer researchers much needed insights for future cure efforts. The authors say their results represent yet another addition to the burgeoning body of evidence to suppress HIV.


Although ART has provided tremendous benefits for prolonging lifespans of those infected with HIV, the regimens have not been able to eliminate the virus from its reservoirs within the body.

Therapeutic vaccination has emerged as a potential strategy to boost people's own immune responses against HIV so they can control the virus without ART.

To study the effectiveness of such an approach, Michael Sneller, Anthony Fauci and colleagues recruited a cohort of HIV-infected individuals from the United States and Canada who had initiated ART shortly after their initial diagnosis.

During a 36-week period where all participants continued ART treatment, 14 people received four injections of a therapeutic HIV vaccine and 15 individuals were administered saline as a control.

When ART was discontinued for 16 weeks under the supervision of the researchers, there was no difference observed in viral rebound between placebo and vaccine groups.

Surprisingly, four people in the placebo group exhibited spontaneous HIV suppression - a substantially greater proportion than would be predicted by the estimated prevalence of so-called "elite HIV controllers" in the general population.

A related Focus by Nelson Michael discusses how these findings further demonstrate the value and importance of well-designed placebo-controlled trials.

Source: Eurekalert
Font : A-A+



Recommended Readings

Latest AIDS/HIV News

HIV Vaccine Clinical Trial Initiates in the United States and South Africa
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.
Beauty Salon-Driven Initiative Boosts PrEP Awareness in Fight Against AIDS
In the United States, African American women make up only 26% of female PrEP users, yet they account for 57% of new infections among women.
Immune-Evading HIV Protein Complex Solved
Scientists have made a groundbreaking discovery in the fight against HIV/AIDS with the successful resolution of the enigmatic immune-evading HIV protein complex.
Does Gender Influence Comorbidity Rates in HIV-Positive Smokers
Tailored quit-smoking programs are designed to address the risks associated with comorbidity in individuals living with HIV.
Digital Test Measures HIV Viral Load
DNA editing tool CRISPR-Cas13 helps diagnose and signal the presence of HIV antibodies in HIV patients.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Therapeutic HIV Vaccine is Not Effective: Clinical Trial Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests